BERWYN, PA — AMETEK, Inc. (NYSE: AME) reported record financial results for the third quarter of 2025, driven by robust demand across its core business segments and continued execution of its growth strategy.
The Pennsylvania-based manufacturer posted sales of $1.89 billion, an 11% increase over the same period in 2024. On a GAAP basis, earnings per diluted share were $1.60, while adjusted earnings reached a record $1.89 per share — up 14% year over year. Adjusted results excluded non-cash acquisition-related amortization and one-time costs associated with the company’s recent purchase of FARO Technologies.
Operating income hit an all-time high of $488.4 million, representing 25.8% of sales. Adjusted operating income rose 11% to $496.1 million, reflecting strong profit growth and margin expansion.
“AMETEK delivered impressive results in the third quarter, highlighted by double-digit growth in sales, orders, and earnings per share, along with an outstanding 90 basis points of margin expansion excluding the impact of recent acquisitions,” said David A. Zapico, AMETEK’s Chairman and Chief Executive Officer. “The strength of the AMETEK Growth Model and the excellent contributions from our colleagues led to record results in the quarter.”
The company’s Electronic Instruments Group (EIG) reported $1.25 billion in sales, up 10% from a year earlier. Operating income rose to $352.4 million, or 28.3% of sales, while adjusted results showed 6% growth. Zapico stated, “EIG delivered solid results in the quarter with strong profit growth and 50 basis points of margin expansion excluding the impact of recent acquisitions. Additionally, we are pleased with the progress of the FARO Technologies integration and excited for the growth opportunities ahead for our expanded metrology platform.”
The Electromechanical Group (EMG) also delivered a standout quarter with sales climbing 13% to $646.3 million. Operating income surged 25% to $163.9 million, with margins improving 250 basis points to 25.4%. “EMG’s third quarter results were outstanding, with broad-based sales and orders growth led by Paragon Medical, resulting in record operating income and sizeable margin expansion,” Zapico noted. “This performance reflects the strength of our differentiated businesses and our unwavering focus on operational excellence.”
Looking ahead, AMETEK raised its full-year earnings guidance. The company now expects adjusted earnings per share in the range of $7.32 to $7.37, up 7% to 8% from 2024 — an increase from previous guidance. Fourth-quarter sales are projected to rise about 10% year over year, with adjusted earnings per share anticipated between $1.90 and $1.95.
“Our businesses performed exceptionally well in the third quarter, delivering strong growth and impressive operating results,” Zapico said. “AMETEK’s flexible operating structure, diverse market exposure, and strong cash flows position us well for sustained success. Our teams continue to execute with excellence and deliver outstanding results in a dynamic environment.”
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.